Jessica Ritsick, Yifan Wang, Ph.D. Our FDA: Drug & Device Team analyzes the Food and Drug Administration’s new guidance on Bayesian approaches to innovative drug trials, providing greater clarity on ...
Authors E. Agnes Blukacz-Richards, Felix Ouellet, Alex Neumann, Dale M. Robertson, Glenn A. Benoy, George B Arhonditsis, David A. Saad ...
The Nature Index 2026 Research Leaders reveal the leading institutions and countries/territories in the natural sciences, health sciences, applied sciences and social sciences, according to their ...
Discussion of "Calibrated Bayes, for Statistics in General, and Missing Data in Particular" by R. J. A. Little Discussion of "Calibrated Bayes, for Statistics in General, and Missing Data in ...
The FDA's move to incorporate Bayesian statistical methods into clinical trials of drugs and biologics garnered special treatment in JAMA this week. JAMA published three perspectives -- two welcoming ...
A Bayesian re-analysis of hundreds of published clinical trials shows that statistically negative studies can hide strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results